이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
China Shineway Pharmaceutical Group 대차 대조표 상태
재무 상태 기준 확인 5/6
China Shineway Pharmaceutical Group 의 총 주주 지분은 CN¥7.0B 이고 총 부채는 CN¥300.0M, 이는 부채 대 자기자본 비율을 4.3% 로 가져옵니다. 총자산과 총부채는 각각 CN¥9.6B 및 CN¥2.5B 입니다. China Shineway Pharmaceutical Group 의 EBIT는 CN¥970.1M 이며 이자보상배율은 -9.4 입니다. CN¥5.9B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
4.5%
부채 비율
CN¥330.00m
부채
| 이자 보상 비율 | -5.7x |
| 현금 | CN¥6.23b |
| 주식 | CN¥7.34b |
| 총 부채 | CN¥2.55b |
| 총 자산 | CN¥9.88b |
최근 재무 상태 업데이트
Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?
May 13
China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly
Sep 28China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Apr 07We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease
Dec 10
Recent updates
If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity
Jun 03Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?
May 13China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461
Apr 26Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?
Apr 17China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461
Mar 31China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings
Mar 14Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?
Jan 29China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly
Sep 28China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118
Sep 01We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Aug 03Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?
May 30We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Mar 07China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125
Sep 01China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 31China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Apr 07China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.
Mar 11Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?
Feb 18Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?
Jan 31Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?
Jan 13What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?
Dec 25We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease
Dec 10Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years
Nov 25재무 상태 분석
단기부채: 2877 의 단기 자산 ( CN¥8.2B )이 단기 부채( CN¥2.4B ).
장기 부채: 2877 의 단기 자산( CN¥8.2B )이 장기 부채( CN¥105.5M ).
부채 대 자본 내역 및 분석
부채 수준: 2877 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: 2877 의 부채 대 자기자본 비율은 지난 5년간 0% 에서 4.3% 로 증가했습니다.
부채 범위: 2877 의 부채는 영업 현금 흐름 ( 310.9% )에 의해 잘 충당되었습니다.
이자 보장: 2877 지불하는 것보다 더 많은 이자를 벌기 때문에 이자 지불 보장은 문제가 되지 않습니다.